PGHH

Procter & Gamble Hygiene & Healthcare Share Price

₹14,567.70 -208.8 (-1.41%)

28 Dec, 2024 01:51

SIP TrendupStart SIP in PGHH

Start SIP

Performance

  • Low
  • ₹14,410
  • High
  • ₹14,892
  • 52 Week Low
  • ₹14,410
  • 52 Week High
  • ₹17,745
  • Open Price₹14,799
  • Previous Close₹14,777
  • Volume4,345

Investment Returns

  • Over 1 Month -8.48%
  • Over 3 Month -11.28%
  • Over 6 Month -9.17%
  • Over 1 Year -15.15%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Hygiene & Healthcare for Steady Growth!

Invest Now

Procter & Gamble Hygiene & Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 69.9
  • PEG Ratio
  • -8.8
  • Market Cap Cr
  • 47,288
  • P/B Ratio
  • 61
  • Average True Range
  • 313.76
  • EPS
  • 208.32
  • Dividend Yield
  • 1.1
  • MACD Signal
  • -190.05
  • RSI
  • 18.25
  • MFI
  • 32.07

Procter & Gamble Hygiene & Healthcare Financials

Procter & Gamble Hygiene & Healthcare Technicals

EMA & SMA

Current Price
₹14,567.70
-208.8 (-1.41%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹15,377.71
  • 50 Day
  • ₹15,750.24
  • 100 Day
  • ₹16,037.49
  • 200 Day
  • ₹16,203.15

Resistance and Support

14623.22 Pivot Speed
  • R3 15,318.38
  • R2 15,105.17
  • R1 14,836.43
  • S1 14,354.48
  • S2 14,141.27
  • S3 13,872.53

What's your outlook on Procter & Gamble Hygiene & Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Hygiene & Health Care Ltd. is a leading Indian company specializing in hygiene and healthcare products. It offers popular brands like Whisper and Vicks, focusing on women's health, personal hygiene, and over-the-counter healthcare solutions.

P&G.Hygiene & Hlth.Care has an operating revenue of Rs. 4,202.51 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 22% is great, ROE of 87% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 17 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 136 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Procter & Gamble Hygiene & Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-30 Quarterly Results
2024-08-28 Audited Results & Final Dividend (Revised) per share(1050%)Final Dividend
2024-04-30 Quarterly Results
2024-01-31 Quarterly Results & Interim Dividend
2023-10-30 Quarterly Results
Date Purpose Remarks
2024-02-09 INTERIM Rs.100.00 per share(1000%)Interim Dividend
2024-02-09 SPECIAL Rs.60.00 per share(600%)Special Dividend
2023-02-08 INTERIM Rs.80.00 per share(800%)Interim Dividend
2022-02-09 INTERIM Rs.95.00 per share(950%)Interim Dividend
2021-05-12 SPECIAL Rs.150.00 per share (1500%) Special Interim Dividend

Procter & Gamble Hygiene & Healthcare F&O

Procter & Gamble Hygiene & Healthcare Shareholding Pattern

70.64%
8.43%
6.82%
1.48%
0.01%
9.81%
2.81%

About Procter & Gamble Hygiene & Healthcare

Procter & Gamble Hygiene and Healthcare Ltd. is a subsidiary of Procter & Gamble (P&G). They are one of India's fastest-growing FMCG companies with a portfolio of brands such as Vicks & Whisper. 

Vicks has been India's leading over-the-counter (OTC) Cough and Cold Brand since its launch in 1952. The products under this brand include Vicks Action500+, Vicks VapoRub, Vicks Cough Drops, Vicks Formula 44 Cough Syrup and Vicks Inhaler.

Whisper is another top feminine hygiene brand with a product portfolio consisting of Whisper Maxi Regular, Whisper Maxi XL Wings, Whisper Ultra with Wings and Whisper Choice.

It’s manufacturing facilities are located in Goa and Baddi in Himachal Pradesh, apart from it the company also has third-party manufacturing plants across India.

Business Verticals

P&G Hygiene and Healthcare Ltd. is engaged in manufacturing, distributing and selling personal health care products. It operates primarily in two segments: Feminine Care Business (Whisper) and Health Care Business (Vicks).

Whisper continues to be the market leader in the feminine care business. The "Comfort & Soft" segment, with the launch of Whisper Choice Aloe Vera's longer length, and the upgrade of their flagship Ultra and Choice portfolio, have transcended customer experience.

In the healthcare business, Procter & Gamble Hygiene and Healthcare Ltd. continued to win despite the challenges due to COVID-19 with the growth of Vicks' portfolio. Vicks 3-in-1 throat lozenges boosted the growth of this segment due to increased demand with world-class communication across all our sub-brands and superior go-to-market strategy. 

Milestones

1964 - On July 20, the Company was incorporated in Mumbai. 

1979 -  The premier product of the company Vicks Action 500 was launched

1985 -
In September, the Company's herbal plant in Annaram, Andhra Pradesh's Medak district, was commissioned to produce herbal and other natural ingredient products. 
Procter & Gamble Co. acquired Richardson-Vicks Inc. in October, and as a result, Richardson Hindustan Ltd. (RHL) became a Procter & Gamble Co. affiliate. Thus, the name of the Company was changed from Richardson Hindustan Ltd. to Procter & Gamble India Ltd. on April 4, 1988.

1992 - The Company introduced Whisper Extra long and Whisper Extra Large.

1993 - The Company High-Quality Whisper with Wings was introduced. 

1995 -
Vicks Vitamin 'C' is a premium line of drops introduced by the Company. 
Whisper Extra Dry, a high-performance sanitary protection product, was introduced by the Company.
The Company ventured to set up a state-of-the-art technology healthcare plant in Goa.

1996 - The Company introduced a test market for Vicks Vaporub Super Balm. 

1998 - Procter & Gamble India Ltd. has now become Procter & Gamble Hygiene and Health Care Ltd.

2000 -
The Company introduced a new brand, Tampax, to the Indian Sanitary napkin market.
Vicks cough drop was reintroduced in a new 2.5 gm blue back.
Vicks Plus medicated lozenges made their way in India.
Gary W. Cofer, country manager, Procter and Gamble, India, is the new managing director of Procter and Gamble Hygiene and Healthcare Ltd. w.e.f. September 1.
Doctoranywhere.com and Procter & Gamble Hygiene & Healthcare join hands.
Vicks Action 5000 was reintroduced in an attractive Blue international pack.

2001 -
The Company launched a Whisper Ultra Day-Night pack for the first time in Tamil Nadu, India.
They kickstarted an outdoor advertising campaign for Vicks Plus medicated lozenges.

2002 - P&G Hygiene and Health Care Ltd. announced that Mr. Gary Cofer would step down as Managing Director on April 1, 2002. Mr. Shantanu Khosla will be named Managing Director.

2003 - The Company launched a new VICKS Formula 44 cough syrup.

2004 -  'Whisper Choice' makes its entry in Tamil Nadu, Andhra Pradesh, Kerala and Karnataka with a pack of 10 pads priced at Rs 26 as a test market launch.

2019 - The Company was awarded the Packaging Innovation Awards 2019 and Best Workplaces for Innovators 2019.

2020 - The Company was awarded Top 25 Most Innovative Client Companies 2020.

View More
  • NSE Symbol
  • PGHH
  • BSE Symbol
  • 500459
  • Managing Director
  • Mr. Kumar Venkatasubramanian
  • ISIN
  • INE179A01014

Similar Stocks to Procter & Gamble Hygiene & Healthcare

Procter & Gamble Hygiene & Healthcare FAQs

Procter & Gamble Hygiene & Healthcare share price is ₹14,567 As on 28 December, 2024 | 01:37

The Market Cap of Procter & Gamble Hygiene & Healthcare is ₹47287.8 Cr As on 28 December, 2024 | 01:37

The P/E ratio of Procter & Gamble Hygiene & Healthcare is 69.9 As on 28 December, 2024 | 01:37

The PB ratio of Procter & Gamble Hygiene & Healthcare is 61 As on 28 December, 2024 | 01:37

Procter & Gamble Hygiene and Health Care Ltd. recorded net sales of INR 3574 as of Jun 21, 2022.

Procter & Gamble Hygiene and Healthcare Ltd. stock is an excellent long-term (1-year) investment with an expected long-term increase in the price.

The Company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23